Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ya B Balzhanova"'
Publikováno v:
Терапевтический архив, Vol 91, Iss 8, Pp 93-97 (2019)
Sorafenib has been used in acute myeloid leukemias with FLT3-ITD mutation improving the outcomes. However the high incidence of treatment - emergent adverse event may be associated with treatment using sorafenib with cytotoxic chemotherapy. We have r
Externí odkaz:
https://doaj.org/article/b9a1b8a086bc4b1b969dc76acafd6130
Autor:
Ya B Balzhanova, A N Sokolov, Elena O. Gribanova, Elena N. Parovichnikova, M A Samtsova, Ryzhko Vv
Publikováno v:
Терапевтический архив, Vol 91, Iss 8, Pp 93-97 (2019)
Sorafenib has been used in acute myeloid leukemias with FLT3-ITD mutation improving the outcomes. However the high incidence of treatment - emergent adverse event may be associated with treatment using sorafenib with cytotoxic chemotherapy. We have r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80cd8fe4454571ba86976ed9ea8e2973
https://pubmed.ncbi.nlm.nih.gov/32598759
https://pubmed.ncbi.nlm.nih.gov/32598759